David Anderson | Chief Scientific Officer
VBI Vaccines

David Anderson, Chief Scientific Officer, VBI Vaccines


A dynamic and well-published immunologist with broad expertise in the areas of vaccine development, autoimmunity and tumor immunology, Dr. Anderson joined VBI full time in 2009 from Harvard Medical School, where he held a position as Assistant Professor.  Dr. Anderson is an inventor of much of the Company’s intellectual property and actively manages its ongoing expansion. Dr. Anderson holds a Ph.D. from Harvard University and a B.S. from the University of California at Davis.

Appearances:



Day 1, September 28 @ 15:50

Panel: What existing treatments and vaccine development platforms show promise to control the rate of infection and spread?

Day 3, September 30th @ 13:40

Targeting CMV for the development of effective GBM and MB immunotherapies

last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT
last published: 28/Sep/20 15:15 GMT

back to speakers